Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer’s disease
Authors:
Open Access
- 1 May 2025
- journal article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 46, 101007
Abstract
No abstract availableKeywords
Funding Information
- National Council for Scientific and Technological Development
- Instituto D'Or de Pesquisa e Ensino
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
- Ministério da Saúde
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 53 references indexed in Scilit:
- Cognitive, behavioral, neuroimaging and inflammatory biomarkers after hospitalization for COVID-19 in BrazilBrain, Behavior, and Immunity, 2023
- Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized PatientsJAMA Network Open, 2022
- Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic SymptomsJAMA Network Open, 2022
- Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementiaAlzheimer's & Dementia, 2022
- Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-upBrain, Behavior, and Immunity, 2021
- Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease developmentInternational Journal of Infectious Diseases, 2021
- Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluidInternational Journal of Infectious Diseases, 2020
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- “Mini-mental state”Journal of Psychiatric Research, 1975